Literature DB >> 9279048

Optometric management of patients with Alzheimer's disease.

D R Baker1, M F Mendez, J C Townsend, P F Ilsen, D C Bright.   

Abstract

BACKGROUND: The earliest symptoms of Alzheimer's disease (AD) may be visual. AD is an age-related, progressive dementia. At least 7% of Americans over 65 years of age are afflicted, and it ranks as the fourth leading cause of death in the United States. A review of the literature was performed to delineate the visual manifestations of Alzheimer's disease.
RESULTS: Abnormal visual perception and visuospatial processing are common among patients with AD Visual acuity, pupillary light reflexes, and the ocular fundus do not appear to be specifically affected by AD. Whether AD impairs color vision is controversial. Stereopsis may also be affected. True visual-field defects are rarely found. Although not universally reported, some studies of contrast sensitivity functions show abnormal sensitivity possibly at low spatial frequencies. The electroretinogram is normal, while the visual evoked response is frequently abnormal.
CONCLUSIONS: As primary eye care providers, optometrists must properly identify and refer individuals with suspected Alzheimer's disease to the appropriate specialist, as well as manage their visual welfare.

Entities:  

Mesh:

Year:  1997        PMID: 9279048

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  5 in total

1.  Axonal Terminals Exposed to Amyloid-β May Not Lead to Pre-Synaptic Axonal Damage.

Authors:  Shu-Wei Sun; Christopher Nishioka; Wessam Labib; Hsiao-Fang Liang
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease.

Authors:  Allison Ning; Jing Cui; Eleanor To; Karen Hsiao Ashe; Joanne Matsubara
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

3.  Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.

Authors:  Jaimie Hoh Kam; Eva Lenassi; Glen Jeffery
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

4.  Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer's Disease.

Authors:  Elena Salobrar-Garcia; Rosa de Hoz; Blanca Rojas; Ana I Ramirez; Juan J Salazar; Raquel Yubero; Pedro Gil; Alberto Triviño; José M Ramirez
Journal:  J Ophthalmol       Date:  2015-05-27       Impact factor: 1.909

5.  Changes in visual function and retinal structure in the progression of Alzheimer's disease.

Authors:  Elena Salobrar-García; Rosa de Hoz; Ana I Ramírez; Inés López-Cuenca; Pilar Rojas; Ravi Vazirani; Carla Amarante; Raquel Yubero; Pedro Gil; María D Pinazo-Durán; Juan J Salazar; José M Ramírez
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.